Duke Clinical Research Institute and Protas partner to transform the quality, accessibility and affordability of randomized clinical trials for common health conditions
Duke Clinical Research Institute (DCRI), the world’s largest academic research organization, will collaborate with Protas, a not-for-profit clinical trials organization led by renowned Oxford Unive
‘Don’t Miss a Beat’: DCRI’s Greene joins Brigham and Women’s Vaduganathan in monthly cardiology research podcast
Duke Clinical Research Institute cardiovascular faculty member Stephen Greene, MD, joins Brigham and Women’s cardi
EMPA-KIDNEY Trial shows benefits for CKD in broad range of patients
A recent trial of empagliflozin expanded the understanding of how the drug can slow chronic kidney disease in a wide range of patients, lowering the risk of disease progression and death from cardi
Forward Together: Locking in Team Culture
Duke Clinical Research Institute builds a lasting tradition around celebrating milestone moments
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
Ivermectin is one of three repurposed medications tested in ACTIV-6, a nationwide double-blind study
Trial finds common malaria prevention regimen reduces complications of sickle cell anemia in Kenyan children
A study by the Duke Clinical Research Institute comparing three treatment methods of preventing malaria in children with sickle cell anemia (SCA) found one method reduces common complications of th
Duke STAR Program trains next generation of research professionals
The latest cohort of young researchers got a head start on learning the skills necessary to build a future in research over the summer, as they completed the Duke STAR program in August, 2022.
DCRI Highlights from AHA Scientific Sessions
Faculty, Fellows Share the Latest Innovative, Impactful Cardiovascular Research
Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery
Less complex heart patients may benefit, but not without risk